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ABSTRACT: This study characterized the distribution of [18F]‐sodium fluoride (NaF) uptake and blood flow in the femur and acetabulum
in hip osteoarthritis (OA) patients to find associations between bone remodeling and cartilage composition in the presence of morpho-
logical abnormalities using simultaneous positron emission tomography and magnetic resonance imaging (PET/MR), quantitative
magnetic resonance imaging (MRI) and femur shape modeling. Ten patients underwent a [18F]‐NaF PET/MR dynamic scan of the hip
simultaneously with: (i) fast spin‐echo CUBE for morphology grading and (ii) T1ρ/T2 magnetization‐prepared angle‐modulated parti-
tioned k‐space spoiled gradient echo snapshots for cartilage, bone segmentation, bone shape modeling, and T1ρ/T2 quantification. The
standardized uptake values (SUVs) and Patlak kinetic parameter (Kpat) were calculated for each patient as PET outcomes, using an
automated post‐processing pipeline. Shape modeling was performed to extract the variations in bone shapes in the patients. Pearson’s
correlation coefficients were used to study the associations between bone shapes, PET outcomes, and patient reported pain. Direct
associations between quantitative MR and PET evidence of bone remodeling were established in the acetabulum and femur. Associations
of shaft thickness with SUV in the femur (p = 0.07) and Kpat in the acetabulum (p = 0.02), cam deformity with acetabular score (p = 0.09),
osteophytic growth on the femur head with Kpat (p = 0.01) were observed. Pain had increased correlations with SUV in the acetabulum
(p = 0.14) and femur (p = 0.09) when shaft thickness was accounted for. This study demonstrated the ability of [18F]‐NaF PET‐MRI, 3D
shape modeling, and quantitative MRI to investigate cartilage‐bone interactions and bone shape features in hip OA, providing potential
investigative tools to diagnose OA. © 2019 The Authors. Journal of Orthopaedic Research® published by Wiley Periodicals, Inc. on behalf
of Orthopaedic Research Society. J Orthop Res 37:2671–2680, 2019
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Osteoarthritis (OA) is the most common debilitating
joint disease, affecting more than 25% of the adult
population. The etiology of OA is multi‐factorial and
includes joint injury, aging, obesity, and hereditary
factors.1 Hip OA is characterized by a number of
pathological changes, including progressive proteo-
glycan loss and collagen disruption in the early stages,
destruction of the articular cartilage, thickening of the
subchondral bone, osteophyte formation, and bone de-
formation in the later stages.2–7 As symptoms of OA do
not manifest until the later more painful stages, hence,
there is a need for establishing biomarkers to detect OA
in its early, reversible stages. Currently, OA pro-
gression is evaluated by measuring joint space nar-
rowing by radiograph based Kellgren–Lawrence (KL)
scores, Croft scores, and minimal joint space width;8,9
however, proteoglycan depletion and water loss occur
before joint space narrowing. Similarly, early changes
in cross‐talk between early bone remodeling and carti-
lage changes have been implicated in the development
of cartilage lesions, joint degeneration, and the pro-
gression of OA.10
T1ρ and T2 relaxation times provide a measure of
proteoglycan content and collagen orientation, re-
spectively, reflecting the cartilage biochemistry and
composition.11,12 In a previous longitudinal study, pa-
tients with hip OA, who demonstrated elongated T1ρ
and T2 relaxation times, developed morphological car-
tilage degeneration, indicating that T1ρ and T2 relaxa-
tion times may be biomarkers for early OA.13 The
three‐dimensional (3D) proximal femur shape varia-
tions were also shown to have associations with mor-
phological and compositional markers of hip joint
degeneration as well as associations with demo-
graphics.6 In addition, studies have shown that [18F]‐
sodium fluoride (NaF) positron emission tomography
and magnetic resonance imaging (PET/MR) is capable
of imaging significant bone and cartilage interactions
in the knee joint.14,15 Associations between pain and
tracer uptake were seen in the absence of morpho-
logical lesions in the cartilage.14 An increase in tracer
uptake in the presence of subchondral bone lesions was
also observed in the knee, concluding that PET/MR
may detect metabolic abnormalities in the subchondral
bone before they are seen on MRI.15 Although the fea-
sibility of [18F]‐NaF PET/MR to image bone cartilage
interactions in the knee has been studied, to the best of
our knowledge, no previous studies have explored the
relationships between bone–cartilage interactions and
bone shape in the hip joint using [18F]‐NaF PET/MR
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along with quantitative MR to detect early biomarkers
of hip OA.
In attempt to fill this gap, this study aims to: (i) char-
acterize the distribution of tracer uptake and blood flow in
the femur and acetabulum in patients with hip OA; (ii)
study associations between bone remodeling and cartilage
composition in the presence of morphological abnormal-
ities using quantitative MR T1ρ and T2 relaxation times,
[18F]‐NaF standardized uptake value (SUV), and Patlak
kinetic parameter (Kpat); and (iii) study bone remodeling
by studying the relationship between MR‐based bone
shape modeling in the femur and [18F]‐NaF‐based bone
remodeling and blood flow using SUVand Kpat.
We hypothesized that patients with cartilage lesions
would demonstrate higher tracer uptake in the bone
surrounding the lesions, indicating bone remodeling
accompanying the cartilage degeneration, and that the
coxa valga femur shape and cam impingment type ab-
normalities would show higher tracer uptake on ac-
count of bone remodeling.
METHODS
This is an analytic study (Level of Evidence: III). All subjects
provided written informed consent and the study was carried
out in accordance with the regulations of the Committee for
Human Research at our institution.
Patient Population
The study was approved by the local institutional review board
(IRB) and a written informed consent was obtained from all
subjects before the study. All the personnel involved with re-
cruitment, scanning, and analysis of this study were Health
Insurance Portability and Accountability Act compliant. Ra-
diographs were obtained prior to the study and Kellgren and
Lawrence3 grading of the radiographs were performed by a
board certified musculoskeletal radiologists with more than 20
years of experience (T.M.L.) to stage the extent of hip OA. The
inclusion criteria included: (i) male or female; (ii) no history of
hip surgery; (iii) no symptomatic knee OA; and (iv) KL
score = 0, 1, 2, and 3. The exclusion criteria included: (i) age<
18; (ii) KL score> 3; (iii) use of an investigational drug for the
duration of the study; (iv) history of diseases that may involve
the studied joint including systemic inflammatory diseases,
crystalline diseases, avascular necrosis, Paget’s disease or tu-
mors; and (v) any contraindications to MRI. All subjects also
completed the Hip disability and Osteoarthritis Outcome Score
(HOOS) survey prior to imaging.16
PET MR Image Acquisition
Image acquisition was performed on SIGNA 3T time of flight
(TOF) PET/MR (GE Healthcare, Milwaukee, WI). The timing
resolution of this scanner as per the manufacturer was less
than 400 ps and a 3D ordered‐subset expectation max-
imization (OSEM) was utilized for all PET reconstructions.
Subjects prepared with an intravenous catheter were
positioned supine feet first, with a large‐size receiver flex coil
wrapped around the hip of interest in the PET/MR. [18F]‐NaF
was used as a tracer, sourced from University of California
San Fransico’s cyclotron facility, produced using current good
manufacturing practices (cGMP) guidelines. Subjects were
injected with an average 247.97± 19.82MBq of [18F]‐NaF for
a dynamic PET scan of 45min. An effective dose of 0.024mSv/
MBq was used to calculate the radiation exposure to each
subject due to the injected [18F]‐NaF.17 A Dixon fat‐water se-
quence was acquired for MR‐based attenuation correction of
PET photons.18 The MR images acquired simultaneously with
PET included (i) 3D isotropic CUBE fast spin‐echo and (ii) 3D
sagittal combined T1ρ/T2. MR and PET acquisition parameters
are shown in Tables 1 and 2, respectively.
MRI Morphologic Grading
Semi‐quantitative clinical grading of the abnormalities of the
articular cartilage and bone marrow was performed by two
radiologists with 3 years of experience, with a Cohen’s κ value
of 0.82 and inter‐rater reliability of 93% between the two
readers. All equivocal cases were reviewed by a senior radi-
ologist with more than 20 years of experience (T.M.L.). The 3D
isotropic CUBE sequences (CUBE, Table 1) with sagittal,
axial, and oblique axial reconstructions were used, which
were similar in quality to 2D fat saturated, intermediate
weighted sequences, to grade according to a system as de-
scribed by Lee et al.20 Cartilage lesions were graded in 10
subregions using a 3‐point scale: 0 for no loss, 1 for partial
thickness loss, and 2 for full thickness loss. The subregions
were the acetabular anterior, femoral anterior, and acetabular
posterior and femoral posterior cartilage in the sagittal image
and the acetabular superolateral, acetabular superomedial,
and femoral lateral, femoral superolateral, femoral super-
omedial and femoral inferior cartilage in the coronal image
(Fig. 1). A total cartilage lesion score was obtained for each
patient. The highest possible cartilage lesion score was 20.
The bone marrow edema (BME)‐like lesion was defined as an
JOURNAL OF ORTHOPAEDIC RESEARCH® DECEMBER 2019
Table 1. Magnetic Resonance Imaging Acquisition Parameters
MR Imaging
Sequence Acquisition Parameters Measurements
Three plane
gradient echo
Localizer for choosing coverage
3D FSE (CUBE) TR/TE = 1200/20ms, FOV= 15.3 cm, matrix
size = 192 × 192, echo train = 32, slice
thickness = 0.8mm
Semi‐quantitative clincal grading of the
bone marrow edema and cartilage
abnormalities
3D combined
T1ρ/T2 MAPSS19
TE = 0/10.4/20.8/41.6ms, TSL = 0/15/30/45ms, spin
lock frequency = 300Hz, FOV= 14 cm, matrix
size = 256 × 128, slice thickness = 4mm
Cartilage T1ρ/T2 measurements, shape
modeling
3D, three‐dimensional; FSE, fast spin‐echo; FOV, field of view; SHOMRI, scoring hip osteoarthritis with MRI; TE, echo time; TR,
repetition time; TSL, time of spin lock.
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ill‐defined subchondral lesion hyperintense on fluid‐sensitive
sequences. These lesions were scored in the same 10 sub-
regions using a 4‐point scale: 0 if no lesion was present, 1 if
equal to or less than 0.5 cm in size, 2 if greater than 0.5 cm but
equal to or less than 1.5 cm, and 3 if greater than 1.5 cm in
size. Each of the 10 subregions were scored separately and
added for a total bone marrow lesion score. The highest pos-
sible bone marrow lesion score was 30.
Image Processing
Image analysis was performed automatically using an in‐
house program developed in MATLAB (Mathworks, Natick,
MA). The 3D shape analysis of the femur was performed using
the methods as previously described by Pedoia et al, using an
atlas‐based method refined by active contours and 3D stat-
istical shape modeling (SSM).21–23 The SSM has the ability to
characterize complex shapes using principal component
analysis (PCA). It identifies the shape differences (features)
empirically, and does not make any assumptions about the
status of OA, therefore, revealing shapes that could have
small variations but are nevertheless still related to OA.
For the combined T1ρ/T2 sequences, non‐rigid registration of
all images was performed on a reference space, which was se-
lected as a patient with average body mass index (BMI). T1ρ and
T2 maps were obtained by fitting the images obtained with dif-
ferent time of spin lock (TSL) and echo time using a Lev-
enberg–Marquardt monoexponential (S(TSL)∝ e−TSL/T1p),
applied to each voxel. The cartilage segmentation, which was
performed manually on the reference space was then applied to
the T1ρ and T2 maps to obtain T1ρ and T2 values in the articular
cartilage for each patient.13
For the PET/MR images, MR images were acquired in the
sagittal plane, while PET images were acquired in the axial
plane for greater coverage. The axial PET data was first re-
sampled into the T1ρ (sagittal) coordinates to transform all the
PET imges into the same orientation and coverage as the MR
images. These transformed images were then registered to the
same reference space as used in the MR images, using a
nonrigid registration.
Almost all 18F‐NaF delivered is retained by bone after a
single pass of blood, and is rapidly cleared as a result of bone
deposition and kidney excretion.24 The arterial input function
(AIF) was measured by automatically isolating the signal of
femoral artery from the PET data, and was used as an ap-
proximation of the plasma input function as the 18F‐ions
briskly equilibriate with the plasma.25 Plotting the PET ac-
tivity in the dynamic PET images divided by the plasma ac-
tivity against normalized time results in a straight line after
15min (equilibration time).26 The extraction or exchange ef-
ficiency may approach 100% in transfer of fluoride ions from
blood to bone, and therefore, the slope of this line (found by
fitting Equation (1)) is stated as Kpat and interpreted as the
influx constant, which is a function of the blood flow.27 Kpat
has been shown to be proportional to blood flow and bone
remodeling in [18F]‐NaF studies,28 therefore, rendering the
Kpat as a useful metric to model blood flow to the bone (femur
and acetabulum). The static PET data was converted to SUV
using the injected dose and patient weight.
( )
( )
=
( )
( )
+
∫t
P t
K
P t dt
P t
V
ROI
t
pat
0
B (1)
ROI(t) is the PET signal measured from a voxel, P(t) is the
plasma input function, and VB is representative of the effec-
tive volume of the distribution of the tracer.
The entire PET and MR image processing was completely
automated and required only the input of all the images of
each sequence.
Individual Case Studies
SUV maps were constructed for each patient and analyzed
qualitatively and quantitatively. A radiologist (T.M.L.) iden-
tified if the tracer uptake was present in regions, which did or
did not have any cartilage or bone marrow lesions. The mean
and maximum SUVand Kpat for each patient along with their
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Table 2. PET Acquisition Parameters
Dynamic PET Acquistion Parameters
Dynamic acquisition time 45min
Onset after injection 0min
Number of phases 3
Number of frames/phase 12 frames of 10 s, 6 frames of
30 s, 10 frames of 4min.
Transverse filter cutoff 6.4mm
Subset 28
Iterations 4
Matrix 256 × 256
FOV 50 cm
FOV, field of view; PET, positron emission tompgraphy.
Figure 1. Hip subregions for morphology
grading. Sagittal MR images were used to
evaluate the AA, FA, AP, and FP subregions.
Coronal MR images were used to evaluate
ASL, ASM, FL, FSL, FSM, and FI subregions.
AA, acetabular anterior; AP, acetabular pos-
terior; ASL, acetabular superolateral; ASM,
acetabular superomedial; FA, femoral ante-
rior; FI, femoral inferior; FL, femoral lateral;
FP, femoral posterior; FSL, femoral supero-
lateral; FSM, femoral superomedial; MR,
magnetic resonance imaging
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mean T1ρ and T2 values were calculated, to give a quantitative
estimate of interactions between cartilage degeneration and
bone remodeling and blood flow.
Associations of Cartilage and Bone Marrow Lesion Scores With
PET Parameters
Overall, Pearson’s correlation coefficients were calculated to
find associations between total cartilage lesion score, BME
lesion score, and quantitative PET parameters (maximum
and mean SUV, maximum and mean Kpat) to identify if car-
tilage and bone marrow lesions can be associated with
changes in bone remodeling and blood flow to bone.
Extraction of Femur Bone Shapes and Their Associations With
PET Parameters and Pain
The mean and maximum SUVand Kpat values were computed
for each patient. The 3D shape modeling was performed on 10
patients as described in the methods to extract the principal
modes that depict the shape variations in the dataset. Pear-
son’s correlation coefficients were calculated to study the as-
sociations between bone shapes and bone remodeling using
PET parameters (SUV and Kpat values). Associations were
also studied to see if the PET uptake could correlate with
pain. An overview of the entire methods process is contained
in Figure 2.
RESULTS
Demographics and MRI Findings
Ten patients were recruited for this study, with eight
patients (80%) graded with KL scores greater than 0,
indicating some sign of hip degenerative changes. The age
of the patients ranged from 37 to 77 years (mean=
56.90± 12.53 years).
Eight patients (80%) exhibited femoral or acetabular
cartilage abnormalities and five patients (50%) had
BME‐like lesions. The overall demographics of patients
are in Table 3 and the distribution of cartilage lesion
and bone marrow abnormality scores of the 10 patients
in all compartments is in Figure 3.
Case Studies
While all patients were looked at, three subject anal-
yses are presented in this paper. The rest of the patient
images can be found in the supplemental material as a
figure. On a single subject basis, an increase in SUV
was observed in proximity of structural abnormalities,
as well as in places not seen as abnormal on the MRI.
Figure 4 shows a T2‐weighted image showing a car-
tilage lesion (blue arrows) in the posterior part of the
acetabular cartilage in a 63‐year‐old male patient with
BMI = 33.98, KL = 2, and pain score = 92.5. This patient
had a total cartilage lesion score of 9 out of a maximum
score of 20, being the patient with the highest cartilage
lesion score. A very high peak of SUV is seen in the
posterior part of the hip near the severe cartilage le-
sion. Adjacent to this region of elevated SUV, elevated
T1ρ and T2 values are seen, with a mean of 38.13 and
34.62ms, respectively. These values are higher than
the means of T1ρ and T2 in all the patients, which are
36.44± 3.07ms and 33.57± 3.95ms, respectively. The
elevated morphological values agree with the high
cartilage score. There is also tracer uptake in the an-
terior part of the femoral head, for which a corre-
sponding abnormality is not seen on the MRI. As
noticed before, the SUV in the acetabulum is greater
than that in the femur, with the mean SUV being 2.42
and 1.90 in the acetabulum and femur, respectively.
Figure 5 shows a BME‐like lesion (blue arrow) in a 60‐
year‐old male OA patient, (BMI= 29.65 kg/m2, KL= 2,
pain score = 72.5) in the T1‐weighted sagittal image. No
uptake is seen corresponding to the region of the edema‐
like lesion seen in the T2‐weighted image (blue arrow).
This patient had a total cartilage lesion score of 5. The
mean SUV was 1.22 in the acetabulum and 0.66 in the
femur. This difference is visible in the SUV map, where
the uptake is much higher in the acetabulum. Highly
elevated values of T1ρ and T2 can be seen in their maps,
respectively, with the area of elevation corresponding to
the elevated SUV location. Moderately elevated values of
T1ρ and T2 are seen in the cartilage corresponding to the
edema indicated by the blue arrow. The mean T1ρ and T2
values for this patient were 40.33 and 39.25ms, which
were higher than the means of the T1ρ and T2 values
values of all 10 patients, which were 36.44± 3.07ms and
33.57± 3.95ms, respectively.
Figure 6 shows BME‐like lesions (blue arrows) in a 49‐
year‐old male OA patient (BMI = 21.62 kg/m2, KL= 0,
pain score = 100) in the T1‐weighted sagittal image. Even
though this patient reported no pain and had KL= 0, his
cartilage lesion score was 4. In addition, this patient had
the highest SUV in the acetabulum when compared with
other patients, with a value of 10.11. As seen in the
figure, the uptake in the acetabulum was higher than
that in the femur, with a mean of 2.15 in the acetabulum
and 1.23 in the femur. Moderately elevated values of T1ρ
and T2 are seen in the cartilage corresponding to the
edemas indicated by the blue arrows. The mean of T1ρ
and T2 values for this patient were 33.72 and 29.55ms,
respectively.
Associations of Cartilage and Bone Marrow Lesion Scores
With PET Parameters
The SUV for all 10 patients was successfully calculated.
The SUVmean in the acetabulum was 2.00± 0.76, which
was significantly higher than SUVmean in the femur,
1.32± 0.47 (p = 0.001). The maximum SUV in all the 10
patients was 10.11 in the acetabulum and 3.88 in the
femur. Overall, more uptake was observed in the ace-
tabulum as described above.
The Kpat values for all 10 patients were computed as
described in the methods, depicting the effective net in-
flux rate of the tracer. Similar to what was observed for
SUV, the mean Kpat in the acetabulum was higher than in
the femur (acetabulum Kpat = 0.015± 0.008min
−1 and
femoral Kpat = 0.007± 0.005min
−1, p= 0.002). The max-
imum Kpat in all the 10 patients was 0.04min
−1 in the
acetabulum and 0.03min−1 in the femur.
While, in our single patient analysis we observed
cases of discordancy between morphological abnor-
mality and SUV, the BME score showed a high
JOURNAL OF ORTHOPAEDIC RESEARCH® DECEMBER 2019
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correlation with the SUVmax in the acetabulum
(r = 0.70, p = 0.02), but not in the femur (r = −0.14,
p = 0.69). The correlation between the BME lesion score
and the SUVmax in the acetabulum was further im-
proved when corrected for by age (r = 0.79, p = 0.006).
The total cartilage lesion score did not show any mod-
erate or strong associations with SUV or Kpat in the
femur or acetabulum.
Extraction of Femur Bone Shapes and Their Associations
With PET Parameters and Pain
The principal modes that depict the shape variations in
the dataset were extracted. Shape features that showed
moderate–strong associations with other imaging data
were further explored. Shape 2 described 21.89% of the
overall variation within the dataset. Shape 2 described
the prominence of the trochanter, with a greater value
of shape 2 corresponding to a larger trochanter. Shape 5
(7.02%) described the size of the femur head compared
with the neck, with an increasing shape value corre-
sponding to a larger femur head. Shape 6 (5.26%) de-
picted the ratio of the radius of the femoral head to the
shaft thickness (subtrochanter region), with a greater
value corresponding to a thicker shaft and smaller
femoral head radius. Shape 7 (2.22) described the neck
shaft angle in the coronal plane. Higher values of shape
7 correspond to a condition known as coxa valga (in-
creased angle) and lower values of shape 7 correspond
to coxa vara (decreased angle). Shape 8 (1.66%) corre-
sponded to a cam impingement abnormality in the
femur head, with an increasing value in the shape
corresponding to a greater impingement. Shape 10
(0.65%) corresponded to a osteophytic growth and
deformity on the superomedial part of the femur
head, with a higher value of shape 10 corresponding
to a femoral head with more growth and deformity.
All the variations in shapes can be visualized in
Figure 7.
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Figure 2. Methods overview. Image acquisition: Three MR sequences were acquired simultaneously with the PET dynamic sequence
(45mins). Image processing and biomarker extraction: The 3D shape modeling, cartilage segmentation, and T1ρ, T2 values along with the
cartilage and BME scores were derived from the MR sequences. The entire PET acquisition was converted to SUV by using the patient
weight and injected activity, and a Patlak analysis was performed to determine the rate of net influx of [18F]‐NaF. Statistical analysis: All
the MR and PET parameters and cartilage and BME scores were inputted into the Pearson correlation analysis. BME, bone marrow
edema; MR, magnetic resonance imaging; NaF, sodium fluoride; PET, positron emission tomography; SUV, standardized uptake value
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For both static and dynamic, the coxa valga shape
showed stronger correlations in the acetabulum when
compared with the femur. It showed a strong positive
correlation with SUV in the acetabulum (r = 0.70,
p = 0.02) and weak correlation in the femur (r = 0.38,
p = 0.27). Similarly, with the mean Kpat, the acetabulum
showed stronger correlations with coxa valga (r = 0.55,
p = 0.09) when compared with femur (r = 0.25, p = 0.48).
The shaft thickness showed a strong correlation with
pain (r = 0.81, p = 0.004). In addition, the shaft thick-
ness showed a moderate positive correlation with the
mean SUV in the femur (r = 0.59, p = 0.07) and a strong
correlation with the maximum Kpat in the acetabulum
(r = 0.70, p = 0.02). The correlation between pain scores
and the maximum uptake was increased when cor-
rected for by shaft thickness (r = 0.12, p = 0.74 to
r = −0.50, p = 0.14) in the acetabulum and in the femur
(r = 0.01, p = 0.97 to r = −0.56, p = 0.09). The cam de-
formity showed weak correlations with PET static and
dynamic parameters. The osseus bump on the femoral
head showed moderate‐to‐strong positive correlations
with the mean femur Kpat (r = 0.69, p = 0.01).
DISCUSSION
This study demonstrated the ability of [18F]‐NaF PET‐
MRI, 3D SSM, and quantitative compositional MRI to
investigate cartilage–bone interactions along with bone
shape features in hip OA. Direct associations between
morphological MR abnormalities and PET evidence of
bone remodeling were established in the acetabulum
and femur.
In a case‐by‐case analysis, certain patients were
found to have elevated SUV in regions surrounding
cartilage lesions, indicating bone remodeling accom-
panying cartilage degeneration. The BME lesion score
showed a high correlation with the SUV in the ace-
tabulum, which increased when corrected for age. For
some of the cases, elevated SUV was found in regions
that did not depict abnormal (cartilage or other tissue)
morphological MRI findings, and these elevations were
accompanied by higher T1ρ and T2 values. These in-
creased uptakes could be considered early changes oc-
curring in the bone–cartilage matrix that cannot be
seen on the morphological MR and may have potential
association with pain. Kobayashi et al.29 showed that
[18F]‐fluoride PET can detect bone abnormalities before
morphological changes are seen on MRI in hip OA, and
that PET uptake may be followed by the appearance of
a BME on the MRI. Kogan et al.15 showed that [18F]‐
fluoride uptake was observed in regions that did not
correspond to structural abnormalities in the knee, and
that it may serve as a marker of early bone remodeling.
Interestingly, the highest tracer uptake in the acetab-
ulum was observed in a patient with KL = 0 with no
pain. Besides that, no significant differences between
tracer uptake, blood flow, or cartilage degeneration
were observed between control and other subjects. This
may suggest that PET and MR findings are visible in
subjects, which have not shown joint space changes in
JOURNAL OF ORTHOPAEDIC RESEARCH® DECEMBER 2019
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their radiographs yet. In this study, correlations were
observed between Kpat in the femur with the T1ρ values.
These could be indicative of increased blood flow to the
femur caused by joint cartilage degeneration. Moreover,
we observed an increased Kpat in regions of the femur
where a slight bump was present. Kogan et al.15 ob-
served higher SUV in lesions identified as osteophytes
in the knee. While we did not see correlations between
SUV and osteophytes, the increase in Kpat in osteo-
phytic regions in the femur could indicate increased
blood flow toward these sites. This agreed with Dyke
et al.,30 who demonstrated that bone blood flow was
related to bone formation. We did not see an association
between cam deformities and PET static or dynamic
parameters, which was unexpected. It could mean that
the deformity had formed and was no longer changing
or remodeling. However, a longitudinal study is clearly
warranted, to determine whether the cartilage degen-
eration follows the change in femur blood flow or vice
versa, that is, if the structural changes in the bone are
responsible for the cartilage degeneration or vice versa.
A longitudinal study is also required to assess if there
are changes in SUV and blood flow during the pro-
gression of the osteophyte formation, that is, if the SUV
is higher while the osteophyte is still growing and re-
duces once the osteophyte has fully formed.
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Figure 3. Hip morphology grade distribution. The cartilage score (left) and bone marrow edema score distribution (as %) in the whole
patient population as graded in the coronal (ASL, ASM, FL, FSL, FSM, FIM) and sagittal (AA, AP, FA, FP) hip images. AA, acetabular
anterior; AP, acetabular posterior; ASL, acetabular superolateral; ASM, acetabular superomedial; FA, femoral anterior; FI, femoral
inferior; FL, femoral lateral; FP, femoral posterior; FSL, femoral superolateral; FSM, femoral superomedial; MR, magnetic resonance
imaging
Figure 4. Left to right: Plane of image acquisition, T2‐weighted focus CUBE image reformatted to a sagittal plane, PET‐MRI fusion
image showing all the SUVs (shown in a hot scale: 0 [black] to 5 [white]), T1ρ map of the articular cartilage using a cartilage mask (shown
in a jet scale, ranging from 0 [blue] to 80 [red] ms) overlaid on the first echo of the T1ρ/T2 sequence, T2 map of the articular cartilage using
a cartilage mask (shown in a jet scale, ranging from 0 [blue] to 80 [red] ms) overlaid on the first echo of the T1ρ/T2 sequence for a 63‐year‐
old male. A very high peak of SUV is seen in the posterior part of the hip near the severe cartilage lesion in the T2‐weighted image (blue
arrow). Adjacent to this region of elevated SUV, elevated T1ρ and T2 values are seen. Tracer uptake in the anterior part of the femoral
head is seen, which does not seem to correspond to any abnormality. MRI, magnetic resonance imaging; PET, positron emission to-
mography; SUV, standardized uptake value
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While pain scores did not show any strong correla-
tions with MR or PET quantitative parameters, pain
scores did show moderate‐to‐strong correlations with
different bone shapes, especially shaft thickness, femur
head size, and presence of a osseus bump. Previous
studies have demonstrated links between certain
proximal femur bone shapes in radiographs and OA.31
In this study, the coxa valga condition was found to
have a strong correlation with the SUV in the acetab-
ulum, which could indicate active bone remodeling in
the acetabulum in the presence of cartilage degener-
ation. Pedoia et al6 showed that the coxa valga shape
might be a good indicator of early OA progression owing
to its correlation with cartilage abnormalities. Pain
scores were found to have increased correlations to T1ρ
when the shaft thickness was taken into account, and
similarly higher correlations between pain and max-
imum SUV were observed after incorporating shaft
thickness. This indicates that the thickness of the
subtrochanter region may be continuously remodeling
to adjust bone architecture to meet the needs of the
changing joint in osteoarthritic patients, which could
manifest as pain and discomfort. A previous study has
used multidimensional data analysis in traits of hip OA
and shown that pain changes during different stages of
the disease.32 This further corroborates the need for a
longitudinal study, to evaluate pain at different stages
of the disease.
This study has promising results, but several limi-
tations need to be considered. First, this was a cross‐
sectional study, which did not allow for the temporal
order of events to be established. A follow‐up study on
the same patients would be needed in order to better
establish the progression of OA and the temporal link
between bone and cartilage changes in OA. Second, the
number of patients recruited was small, and a larger
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Figure 5. Left to right: Plane of image acquisition, T1‐weighted sagittal image, PET‐MRI fusion image showing all the SUVs (shown in a hot
scale: 0 [black] to 5 [white]), T1ρ map of the articular cartilage using a cartilage mask (shown in a jet scale, ranging from 0 [blue] to 80 [red]ms)
overlaid on the first echo of the T1ρ/T2 sequence, T2 map of the articular cartilage using a cartilage mask (shown in a jet scale, ranging from 0
[blue] to 80 [red]ms) overlaid on the first echo of the T1ρ/T2 sequence for a for a 60‐year‐old male. No uptake is seen corresponding to the region of
the edema‐like lesion seen in the T2‐weighted image (blue arrow). Highly elevated values of T1ρ and T2 in the posterior aspect of the joint can be
seen in their maps, respectively, with the area of elevation corresponding to SUV elevation location. MRI, magnetic resonance imaging; PET,
positron emission tomography; SUV, standardized uptake value
Figure 6. Left to right: Plane of image acquisition, T1‐weighted sagittal image, PET‐MRI fusion image showing all the SUVs (shown in
a hot scale: 0 [black] to 5 [white]), T1ρ map of the articular cartilage using a cartilage mask (shown in a jet scale, ranging from 0 [blue] to
80 [red] ms) overlaid on the first echo of the T1ρ/T2 sequence, T2 map of the articular cartilage using a cartilage mask (shown in a jet scale,
ranging from 0 [blue] to 80 [red] ms) overlaid on the first echo of the T1ρ/T2 sequence for a for a 49‐year‐old male. Bone marrow edema‐like
lesions (blue arrows) are seen in the T1‐weighted image. In addition, this patient had the highest SUV in the acetabulum when compared
with other patients, with a value of 10.11. Moderately elevated values of T1ρ and T2 are seen in the cartilage corresponding to the edemas
indicated by the blue arrows. MRI, magnetic resonance imaging; PET, positron emission tomography; SUV, standardized uptake value
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study will have to be performed to see if these corre-
lations and associations are generalizable. A larger
study would also be useful in determining the patterns
seen in patients that demonstrate tracer uptake in the
absence of lesions versus those who show uptake in the
presence of lesions. Third, the bone shape analysis was
done on low‐resolution images. The shape modeling
would be improved if performed on smaller, isotropic
voxels, which would allow for smaller deformities and
local changes to be detected. Furthermore, having more
patients would help identify any shapes that may not
be in this dataset, but could still be important for OA
prediction. While OA is often characterized and diag-
nosed by pain, this occurs in later stages of the disease,
which are then irreversible. This study was a step to
probe hip joint changes on a pathological level in the
early stages of the disease, unleashing potential to di-
agnose hip OA early with possibility for intervention
and treatment. Thus, overall, this study provides sev-
eral insights into the relationship between cartilage
biochemistry, bone shape, and bone remodeling in pa-
tients with hip OA, and the potential to understand the
pathophysiology of disease and directed interventions
using these tools are an exciting step forward in the
field of OA and musculoskeletal degeneration.33–36
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